Back to search

United Kingdom· GB-APID-34549111000001108

Natacyn 5% ophthalmic suspension

A natamycin product containing natamycin, registered in United Kingdom by Imported (United States). The same ATC class is registered in 4 of our 19 countries.

ATC S01AA10

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedNatacyn 5% ophthalmic suspensionATCS01AA10REGISTER NO.GB-APID-3454911100000…PACKS LISTED0CHECKEDSeptember 13, 2026

Where it is registered

Natamycin is registered in 4 of 19 countries.

Countries holding a registration under ATC S01AA10 (natamycin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 3 of them publish a price we can compare per daily dose

Natamycin · ATC S01AA10

4 / 19 countries

  • Finlandprice
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Natamycin
Manufacturer
Imported (United States)
Country
United Kingdom (GB)
ATC code
S01AA10
ATC class
Natamycin
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Natamycin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All natamycin products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Czechia · Pimafucin
  • Finland · Pimafucin
  • Hungary · Pimafucin
  • Poland · Pimafucin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1ca56ab2-bdca-44d0-84da-c2a4a86c618d
GET /v1/drugs/1ca56ab2-bdca-44d0-84da-c2a4a86c618d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "34549111000001108",
  "desc": "Natacyn 5% ophthalmic suspension (Imported (United States))",
  "form": "Eye drops",
  "vpid": "34548911000001103",
  "source": "dmd",
  "vtm_id": "776877007",
  "strength": "50 mg",
  "substance": "Natamycin",
  "ingredient": "Natamycin",
  "supplier_code": "11821411000001108"
}

See everything about natamycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.